EverQuote, Inc. (NASDAQ:EVER – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight analysts that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and six have given a buy recommendation to the company. The average 12-month target price among analysts that have issued a report on the stock in the last year is $28.1667.
EVER has been the subject of several recent analyst reports. JPMorgan Chase & Co. began coverage on EverQuote in a research note on Monday, August 24th. They issued an “overweight” rating and a $29.00 price target for the company. Raymond James Financial reissued an “outperform” rating and issued a $28.00 target price on shares of EverQuote in a report on Thursday, August 13th. Needham & Company LLC upped their target price on shares of EverQuote from $25.00 to $30.00 and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Weiss Ratings raised shares of EverQuote from a “hold (c)” rating to a “hold (c+)” rating in a research note on Wednesday. Finally, Wall Street Zen cut shares of EverQuote from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th.
Get Our Latest Stock Report on EVER
Insider Transactions at EverQuote
Hedge Funds Weigh In On EverQuote
Institutional investors have recently bought and sold shares of the business. Comerica Bank increased its holdings in shares of EverQuote by 235.4% in the 3rd quarter. Comerica Bank now owns 1,100 shares of the company’s stock worth $25,000 after buying an additional 772 shares during the last quarter. Signature Equity Partners LLC lifted its holdings in shares of EverQuote by 65.5% in the 1st quarter. Signature Equity Partners LLC now owns 2,127 shares of the company’s stock valued at $33,000 after acquiring an additional 842 shares during the last quarter. NewEdge Advisors LLC purchased a new position in EverQuote in the third quarter worth about $52,000. Clearstead Advisors LLC grew its position in EverQuote by 70.5% in the fourth quarter. Clearstead Advisors LLC now owns 1,997 shares of the company’s stock worth $54,000 after acquiring an additional 826 shares in the last quarter. Finally, Tower Research Capital LLC TRC increased its stake in EverQuote by 271.2% during the second quarter. Tower Research Capital LLC TRC now owns 3,259 shares of the company’s stock worth $79,000 after acquiring an additional 2,381 shares during the last quarter. Institutional investors own 91.54% of the company’s stock.
EverQuote Price Performance
EVER opened at $25.66 on Monday. The firm has a market cap of $924.53 million, a P/E ratio of 8.33 and a beta of 0.62. EverQuote has a 1-year low of $13.88 and a 1-year high of $28.73. The company has a 50 day simple moving average of $24.85 and a two-hundred day simple moving average of $19.82.
EverQuote (NASDAQ:EVER – Get Free Report) last released its earnings results on Monday, August 3rd. The company reported $0.53 earnings per share for the quarter, beating analysts’ consensus estimates of $0.52 by $0.01. The company had revenue of $195.09 million for the quarter, compared to analysts’ expectations of $191.06 million. EverQuote had a net margin of 15.16% and a return on equity of 50.29%. EverQuote’s revenue for the quarter was up 24.6% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.39 EPS. Equities analysts anticipate that EverQuote will post 1.72 earnings per share for the current year.
EverQuote Company Profile
EverQuote, Inc operates an online insurance marketplace that connects consumers with insurance providers across the United States. Founded in 2011 and headquartered in Cambridge, Massachusetts, the company leverages proprietary technology to match individuals seeking coverage with insurers offering competitive rates. Since its initial public offering in 2020, EverQuote has focused on expanding its digital platform and enhancing the efficiency of its lead-generation processes.
The company’s core business centers on a quote-comparison engine for personal auto, home, and health insurance products.
See Also
- Five stocks we like better than EverQuote
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
- Snowflake Is Up Nearly 50% in 2026—What Are Short Sellers Betting Against?
Receive News & Ratings for EverQuote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EverQuote and related companies with MarketBeat.com's FREE daily email newsletter.
